Otto Bock HealthCare GmbH:企業の戦略的SWOT分析

◆英語タイトル:Otto Bock HealthCare GmbH - Strategic SWOT Analysis Review
◆商品コード:GDME6370SA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Otto Bock HealthCare GmbH – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Otto Bock HealthCare GmbH (Otto Bock), a subsidiary of Otto Bock Holding GmbH & Co. KG is a medical device company that manufactures and distributes prosthetic and orthotic devices. It offers mobility and seating solutions for the physically disabled adults and children. The product portfolio of the company includes prosthetics for limbs, joints, breasts, and extremities; wheelchairs, custom seating, walkers, and support and compression stockings; and back support bandages and shower seats. It offers an extensive range of patient care and professional services through its supply centers the world over. The company, along with its subsidiaries, operates in Asia-Pacific, Europe, Americas and Africa. Otto Bock is headquartered in Duderstadt, Germany.

Otto Bock HealthCare GmbH Key Recent Developments

Jan 08,2020: Cascade Orthopedic Supply announces investment by Ottobock North America
Dec 19,2019: Ottobock trainees present donation to Georgia-Augusta Red Cross Nurses
Dec 18,2019: Ottobock: Jenny Fleischer named Vice President Marketing Excellence
Dec 13,2019: Investment Plan for Europe: EIB continues to expand life-sciences activities providing funding of up to €100 million to Ottobock
Dec 10,2019: 10-year anniversary of the Max Näder Center for Rehabilitation Technologies and Outcomes Research

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Otto Bock HealthCare GmbH – Key Facts
Otto Bock HealthCare GmbH – Key Employees
Otto Bock HealthCare GmbH – Key Employee Biographies
Otto Bock HealthCare GmbH – Major Products and Services
Otto Bock HealthCare GmbH – History
Otto Bock HealthCare GmbH – Company Statement
Otto Bock HealthCare GmbH – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Otto Bock HealthCare GmbH – Business Description
Otto Bock HealthCare GmbH – SWOT Analysis
SWOT Analysis – Overview
Otto Bock HealthCare GmbH – Strengths
Otto Bock HealthCare GmbH – Weaknesses
Otto Bock HealthCare GmbH – Opportunities
Otto Bock HealthCare GmbH – Threats
Otto Bock HealthCare GmbH – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Year, 2014 to YTD 2020
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Type, 2014 to YTD 2020
Otto Bock HealthCare GmbH, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 08, 2020: Cascade Orthopedic Supply announces investment by Ottobock North America
Dec 19, 2019: Ottobock trainees present donation to Georgia-Augusta Red Cross Nurses
Dec 18, 2019: Ottobock: Jenny Fleischer named Vice President Marketing Excellence
Dec 13, 2019: Investment Plan for Europe: EIB continues to expand life-sciences activities providing funding of up to €100 million to Ottobock
Dec 10, 2019: 10-year anniversary of the Max Näder Center for Rehabilitation Technologies and Outcomes Research
Jul 05, 2019: Gungor Kara appointed new Chief Digital Officer of Ottobock
Jun 24, 2019: Jorg Wahlers appointed new Chief Financial Officer
May 23, 2019: Ottobock creates considerable value
Jan 22, 2019: Management Board appoints Philipp Schulte-Noelle as CEO
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Otto Bock HealthCare GmbH, Key Facts
Otto Bock HealthCare GmbH, Key Employees
Otto Bock HealthCare GmbH, Key Employee Biographies
Otto Bock HealthCare GmbH, Major Products and Services
Otto Bock HealthCare GmbH, History
Otto Bock HealthCare GmbH, Subsidiaries
Otto Bock HealthCare GmbH, Key Competitors
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Year, 2014 to YTD 2020
Otto Bock HealthCare GmbH, Medical Equipment, Deals By Type, 2014 to YTD 2020
Otto Bock HealthCare GmbH, Recent Deals Summary

★海外企業調査レポート[Otto Bock HealthCare GmbH:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nielsen Holdings PLC:企業の戦略・SWOT・財務分析
    Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • US Foods, Inc.:企業の戦略・SWOT・財務分析
    US Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary US Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • FibroGen Inc (FGEN)-製薬・医療分野:企業M&A・提携分析
    Summary FibroGen Inc (FibroGen) is a biotechnology company that discovers, develops and commercializes new therapeutics. The company’s pipeline product portfolio includes FG-4592, an oral small molecule inhibitor of HIF prolyl hydroxylases that is used for the treatment of anemia in chronic kidney d …
  • Hon Hai Precision Industry Co Ltd (2317):企業の財務・戦略的SWOT分析
    Hon Hai Precision Industry Co Ltd (2317) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Annexon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Annexon Inc (Annexon) is a developer of therapeutic products and pathway inhibitors for the treatment of neurological disorders. The company develops treatments for Huntington’s disease and Alzheimer’s disease by targeting complement-mediated neurodegeneration. Its lead drug candidates inclu …
  • NorthWestern Corp (NWE):石油・ガス:M&Aディール及び事業提携情報
    Summary NorthWestern Corp, doing business as NorthWestern Energy, is an electric and natural gas utility. It generates, transmits, and electricity, and also carries out mid-stream operations. The company produces from wind, hydro, solar, coal, and natural gas. NorthWestern Energy produces, stores, t …
  • Khatam al-Anbia:企業の戦略的SWOT分析
    Khatam al-Anbia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • AzurRx BioPharma Inc (AZRX):企業の財務・戦略的SWOT分析
    AzurRx BioPharma Inc (AZRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Toma Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Toma Biosciences Inc (Toma Biosciences) is a provider of genome sequencing solutions. The company launched TOMA OS-Seq cancer assay to laboratories and researchers for the changes in tumors. Its products include reagent kits that are developed to detect genomic changes in cancer and TOMA OS- …
  • Four Seasons Hotels and Resorts:企業の戦略的SWOT分析
    Four Seasons Hotels and Resorts - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Exelixis Inc (EXEL)-製薬・医療分野:企業M&A・提携分析
    Summary Exelixis Inc (Exelixis) is a biopharmaceutical company focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabometyx (c …
  • ShawCor Ltd (SCL):石油・ガス:M&Aディール及び事業提携情報
    Summary ShawCor Ltd (ShawCor), formerly Shaw Industries Ltd, is an integrated energy services company. It provides a range of technology-based products, services and solutions, which include pipe coating services, flexible composite pipes, onshore and offshore pipeline corrosion and thermal protecti …
  • JFE Holdings, Inc. (5411):企業の財務・戦略的SWOT分析
    JFE Holdings, Inc. (5411) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gordon Food Service Inc:企業の戦略的SWOT分析
    Gordon Food Service Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • De Lage Landen International B.V.:企業の戦略・SWOT・財務情報
    De Lage Landen International B.V. - Strategy, SWOT and Corporate Finance Report Summary De Lage Landen International B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Ginza Project:企業の戦略・SWOT・財務情報
    Ginza Project - Strategy, SWOT and Corporate Finance Report Summary Ginza Project - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Vior Inc (VIO):企業の財務・戦略的SWOT分析
    Summary Vior Inc (Vior) is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of gold and silver metal properties in North and Latin America. Its projects comprise Mosseau Gold project, Foothills Rutile project, Vezza-Noyard Go …
  • M.D.C. Holdings Inc:戦略・SWOT・企業財務分析
    M.D.C. Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary M.D.C. Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Jardine Engineering Corporation, Limited
    Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆